Document Classification

Section Type: RESULTS

Text: Conversely, treatment with DHEA (a) increased (P < 0. 001 vs. baseline) platelet cGMP (111. 9 + / - 7. 1 vs. 50. 1 + / - 4. 1 fmol/10 (6) plts), DHEA-S (13. 6 + / - 0. 8 vs. 3. 0 + / - 0. 3 micromol/l), DHEA (23. 6 + / - 1. 7 vs. 15. 3 + / - 1. 4 nmol/l), testosterone (23. 6 + / - 1. 0 vs. 17. 7 + / - 1. 0 nmol/l) and E (2) (72. 0 + / - 5. 0 vs. 60. 0 + / - 4. 0 pmol/l) ; and (b) decreased (P < 0. 05 vs. baseline) PAI-1 Ag (27. 4 + / - 3. 8 vs. 21. 5 + / - 2. 5 ng/ml) and low-density lipoprotein (LDL) cholesterol (3. 4 + / - 0. 2 vs. 3. 0 + / - 0. 2 mmol/l).